Edmund Optics: Minimize Ultrafast Pulse Spreading with Low Group Delay Dispersion Optics

Edmund Optics, a leading global manufacturer and supplier of optical components, now internally manufactures short pulse optics with low group delay dispersion (GDD) out of Edmund Optics Florida, formerly known as Quality Thin Films (QTF). These optics minimize chromatic aberration and pulse spreading in ultrafast laser systems, resulting in higher peak powers.

Edmund Optics®, Leading Global Manufacturer And Supplier Of Optical Components, Now Internally Manufactures Short Pulse Optics With Low Group Delay Dispersion (Gdd) Out Of Edmund Optics Florida, Formerly Known As Quality Thin Films (Qtf).

Before being acquired by Edmund Optics, Quality Thin Films (QTF), a leading laser optics manufacturer, had the ability to design and coat low GDD optics, though they lacked the metrology required to verify the specifications. Customer feedback showed that the optics performed well, but this could not be confirmed in-house. Edmund Optics uses white light interferometers and an in-house ultrafast laser to measure GDD, allowing measurement of these challenging optics to verify their performance in real environments.

Low GDD optics from Edmund Optics Florida are measured before they are shipped, guaranteeing GDD specifications from 250 to 3,200 nm within +- 10 fs². Whether you require low GDD mirrors, filters, or other ultrafast optics, Edmund Optics has the manufacturing and metrology technology to create a solution for you.

Edmund Optics Florida excels in manufacturing a wide variety of laser optics including laser crystals, high laser-induced damage threshold optics, and now low GDD optics.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version